Regulation of divalent metal transporter (DMT) by tumor necrosis factor and lipopolysaccharide is dependent on NF-kappaB in SH-SY5Y neuroblastoma cells
by Alex, Garrick James, M.A., STATE UNIVERSITY OF NEW YORK AT BUFFALO, 2009, 83 pages; 1469052

Abstract:

Disturbance in metal homeostasis can lead to a variety of diseases such hemochromatosis, which occurs when systemic iron overwhelms the bodies' transferrin sequestering capacity, and anemia. Neurodegenerative disorders result in iron deposition at the site of the lesion and it is theorized that this may play a role in exacerbating a degenerative cascade. One of the principle proteins involved in maintaining proper metal homeostasis is divalent metal transporter (DMT-1) which has been shown to be the major transporter of metals in the brain.

There are four known variants of DMT-1: The 1A and 1B isoforms, differing at the transcriptional start site and the +IRE and –IRE isoforms, based on the presence or lack of an iron response element (IRE) in the 3' untranslated region of the message. Previous in vitro studies have observed augmentation in the +IRE and –IRE isoforms of DMT-1 in the presence tumor necrosis factor (TNF-α), lipopolysacchride (LPS), and interferon-gamma (IFN-γ). Additional research has revealed that the 1B isoforms of DMT-1 are regulated by the transcription factor NF-κB.

Previous studies demonstrated +IRE and –IRE protein induction occurred in the presence of well known NF-κB agonists and subsequent mitigation occurred with NF-κB inhibition while 1A protein levels were relatively unaffected. It is a reasonable hypothesis that this augmentation that occurred in the presence of TNF-α and LPS is mediated by NF-κB and that the 1B isoforms of DMT-1 are the most influenced. BEAS-2B lung epithelial were used in an attempt to mimic a previous experiment and confirm results. SH-SY5Y cells are a common model for neuronal tissue and have been used extensively and successfully for DMT-1 research. The SH-SY5Y cells were used to determine whether the +IRE, -IRE, and 1A isoforms of DMT-1 are regulated by TNF-α and LPS in a NF-κB mediated fashion, via inhibition of NF-κB by the cell permeable peptide SN-50. Furthermore, removal of the 1A isoforms by sequential immuno-precipitation theoretically provides a possible way to measure 1B expression under the same conditions.

The results of this study revealed that SH-SY5Y cells experienced an induction of 1B mRNA when exposed to TNF-α or LPS. Palliation of this induction occurred when NF-κB was inhibited by SN-50. Message level was measured by use of Reverse Transcriptase-PCR. Western blot analysis revealed that exposure to TNF-α or LPS significantly augmented +IRE and –IRE protein levels. This increase in +IRE and –IRE protein was mitigated by inhibition of NF-κB by SN-50, with the –IRE protein decreasing below basal levels. 1A immuno-depleted/-IRE protein levels confirmed this observation as a significant increase in 1A depleted/–IRE protein was observed with TNF-α or LPS challenged cells. Inhibition of NF-κB resulted in sub basal expression of 1A depleted/-IRE DMT-1, which is similar to what was observed with the –IRE protein. The 1A isoforms of DMT-1 remained relatively unchanged by NF-κB activation or inhibition. BEAS-2B cells experienced augmentation of 1B message level in the presence of TNF-α and subsequent palliation of 1B message levels by NF-κB inhibition.

Overall, DMT-1 in SH-SY5Y cells was found to be augmented by TNF-α and LPS in a NF-κB dependent manner. The –IRE form of DMT-1 was the most dramatically influenced by NF-κB. Removal of the 1A isoforms via immuno-precipitation revealed that the 1A depleted/-IRE protein is likely a significant component of total DMT-1 levels in SH-SY5Y cells and is the major form mediated by NF-κB. It is likely that what is observed in –IRE probing of the 1A depleted lysate is representative of the 1B/-IRE species of DMT-1, as removal of 1A protein means remaining –IRE and +IRE isoforms must be associated with 1B DMT-1.

 
AdviserJerome Roth
SchoolSTATE UNIVERSITY OF NEW YORK AT BUFFALO
SourceMAI/ 48-01, Nov 2009
Source TypeThesis
SubjectsMolecular biology; Pharmacology
Publication Number1469052
Adobe PDF Access the complete dissertation:
 

» Find an electronic copy at your library.
  Use the link below to access a full citation record of this graduate work:
  http://gateway.proquest.com/openurl%3furl_ver=Z39.88-2004%26res_dat=xri:pqdiss%26rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation%26rft_dat=xri:pqdiss:1469052
  If your library subscribes to the ProQuest Dissertations & Theses (PQDT) database, you may be entitled to a free electronic version of this graduate work. If not, you will have the option to purchase one, and access a 24 page preview for free (if available).

About ProQuest Dissertations & Theses
With over 2.3 million records, the ProQuest Dissertations & Theses (PQDT) database is the most comprehensive collection of dissertations and theses in the world. It is the database of record for graduate research.

The database includes citations of graduate works ranging from the first U.S. dissertation, accepted in 1861, to those accepted as recently as last semester. Of the 2.3 million graduate works included in the database, ProQuest offers more than 1.9 million in full text formats. Of those, over 860,000 are available in PDF format. More than 60,000 dissertations and theses are added to the database each year.

If you have questions, please feel free to visit the ProQuest Web site - http://www.proquest.com - or call ProQuest Hotline Customer Support at 1-800-521-3042.